Rhythm Pharmaceuticals Inc (NASDAQ:RYTM)

Delayed Data
As of 3:59pm ET
 +1.05 / +5.46%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Rhythm Pharmaceuticals Inc have a median target of 31.00, with a high estimate of 43.00 and a low estimate of 18.00. The median estimate represents a +52.94% increase from the last price of 20.27.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Rhythm Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -5.77%
Growthannually 11.03%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.